| Disclosure of reconciliation of other equity instruments |
The following tables summarize the data relating to BCEs as well as the assumptions used for the measurement thereof in accordance with IFRS 2 – Share-based Payment: | | | | | | | | | | | | | | | | | | | | | | | | NUMBER OF BCE OUTSTAND ING AS OF JANUARY 1, 2025 | | | | | | | NUMBER OF BCEs OUTSTAND ING | | NUMBER OF BCEs EXERCISA BLE | | MAXIMUM NUMBER OF SHARES TO BE ISSUED IF ALL CONDITIO NS ARE MET | | | | YEAR ENDED DECEMBER 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following tables summarize the data relating to BSAs as well as the assumptions used for the measurement thereof in accordance with IFRS 2—Share-based Payment: | | | | | | | | | | | | | | | | | | | | | | Total NUMBER OF BSAs ISSUED | | NUMBER OF BSAs OUTSTAND ING AS OF JANUARY 1, 2025 | | | | | | | NUMBER OF BSAs OUTSTAND ING | | NUMBER OF BSAs EXERCISA BLE | | MAXIMUM NUMBER OF SHARES TO BE ISSUED IF ALL CONDITIO NS ARE MET | | | | YEAR ENDED DECEMBER 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following tables summarize the data relating to AGAs as well as the assumptions used for the measurement thereof in accordance with IFRS 2—Share-based Payment: | | | | | | | | | | | | | | | | | | Total NUMBER OF AGAs ISSUED | | NUMBER OF AGAs OUTSTANDING AS OF JANUARY 1, 2025 | | | | | | | NUMBER OF AGAs OUTSTANDING | | | | YEAR ENDED DECEMBER 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Disclosure of main data and assumptions used for the measurement of other equity instruments |
The fair value of the BSAs was determined at grant date using the Black Scholes model, with the following assumptions: | | | | | | | | | | | | | | | | | | | FAIR VALUE OF THE UNDERLYING SHARE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | FAIR VALUE OF THE UNDERLYING SHARE | | | | | | | | | | | AGA 2023-1 (Tranches 1-4) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The fair value of the Minimum Return Indemnifications was measured using the following assumptions: | | | | | Tranche B Minimum Return Indemnification (issued in March 2024) | | | | | Final redemption scenario probability | | | | | | | | | | | | | | | Probability-weighted present value of shortfall payment (in thousands of €) | | 1,959 (Final redemption) 68 (Tender offer) | | 2,635 (Final redemption) 136 (Tender offer) | Probability-weighted fair value of tranche A-B warrants with MRI (in thousands of €) | | | | | Probability-weighted fair value of tranche A-B warrants without MRI (in thousands of €) | | | | | Total fair value of MRI (in thousands of €) | | 1,615 (Final redemption, i.e. a+b-c) 68 (Tender offer) | | 2,499 (Final redemption, i.e. a+b-c) 136 (Tender offer) | Fair value of Tranche B MRI (in thousands of €) | | | | |
| | | | | Tranche C Minimum Return Indemnification (issued in June 2024) | | | | | Final redemption scenario probability | | | | | | | | | | | | | | | (a) Probability-weighted present value of shortfall payment (in thousands of €) | | 741 (Final redemption) 0 (Tender offer) | | 1,160 (Final redemption) 43 (Tender offer) | (b) Probability-weighted fair value of tranche C warrants with MRI (in thousands of €) | | | | | (c) Probability-weighted fair value of tranche C warrants without MRI (in thousands of €) | | | | | Total fair value of MRI (in thousands of €) | | 475 (Final redemption, i.e. a+b-c) 0 (Tender offer) | | 941 (Final redemption, i.e. a+b-c) 43 (Tender offer) | Fair value of Tranche C MRI (in thousands of €) | | | | |
The main data and assumptions are the following: | | | | | | | Kreos/Claret Tranche A-B BSA - August 2023 | | AS OF AUGUST 22, 2023 (Tranche A-B) | | | | | Number of outstanding BSA | | | | | | | | | | | | | | | | | | | | | | | 19/08/2030 (expiry) 18/02/2027 (tender offer) | | 19/08/2030 (expiry) 18/02/2027 (tender offer) | | 19/08/2030 (expiry) 18/02/2027 (tender offer) | 7-year expiry scenario probability | | | | | | | | | 71.9% (expiry) 65.2% (tender offer) | | 59.5% (expiry) 64.9% (tender offer) | | 44.3% (expiry) 44.3% (tender offer) | | | | | | | | | | | | | | 2.9% (expiry) 2.9% (tender offer) | Fair value of issued Kreos/Claret Tranche A-B BSA | | | | | | |
| | | | | | | Kreos/Claret Tranche C BSA - November 2023 | | | | | | | Number of outstanding BSA | | | | | | | of which, number of conditional BSA | | | | | | | | | | | | | | | | | | | | | | | 01/11/2030 (expiry) 18/02/2027 (tender offer) | | 01/11/2030 (expiry) 18/02/2027 (tender offer) | | 01/11/2030 (expiry) 18/02/2027 (tender offer) | 7-year expiry scenario probability | | | | | | | Probability of Drawdown of Tranche C credit facility | | | | | | | | | 67.3% (expiry) 64.3% (tender offer) | | 67.4% (expiry) 64.9% (tender offer) | | 44.3% (expiry) 44.3% (tender offer) | | | | | | | | | | | | | | 2.9% (expiry) 2.9% (tender offer) | Fair value of issued Kreos/Claret Tranche C BSA | | | | | | |
|